西陇科学部分实控人拟集体减持 套现约为1.7亿元

Core Viewpoint - The actual controllers of Xilong Science plan to reduce their holdings by a total of 17.56 million shares, accounting for 3% of the total share capital, to meet personal financial needs and repay pledged financing [2][3][5] Shareholder Reduction Plan - Huang Weibao plans to reduce 9,456,400 shares, representing 1.62% of the total shares - Huang Weipeng plans to reduce 4,000,000 shares, representing 0.68% of the total shares - Huang Zhenkai plans to reduce 1,200,000 shares, representing 0.21% of the total shares - Huang Zhenjie plans to reduce 2,900,000 shares, representing 0.50% of the total shares - The total reduction amounts to 17,556,400 shares, or 3.00% of the total shares [3] Financial Performance - In the first half of 2025, Xilong Science achieved revenue of 3.368 billion yuan, a year-on-year decrease of 14.78% - The company reported a net loss of 75.32 million yuan, a shift from profit to loss compared to the previous year - The net profit excluding non-recurring items was 39.58 million yuan, a year-on-year decrease of 3.90% - The revenue decline was primarily due to reduced income from chemical raw material trading and specialized chemical products [4] Control and Governance - If the planned share reduction is fully executed, the actual controllers and their concerted actors will still hold 22.61% of Xilong Science's shares - This reduction will not lead to a change in control and will not adversely affect the governance structure or ongoing operations of the company [5]